The current system for prescribing antiretroviral therapy puts HIV-infected patients at risk of serious drug-drug interactions: is now the time for a paradigm shift in HIV care delivery?

Clin Med (Lond). 2012 Jun;12(3):300-1. doi: 10.7861/clinmedicine.12-3-300.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Androstadienes* / administration & dosage
  • Androstadienes* / pharmacokinetics
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / pharmacokinetics
  • Anti-Retroviral Agents* / administration & dosage
  • Anti-Retroviral Agents* / adverse effects
  • Anti-Retroviral Agents* / pharmacokinetics
  • Delivery of Health Care, Integrated / organization & administration*
  • Disease Management
  • Drug Interactions
  • Fluticasone
  • HIV Infections / drug therapy*
  • Humans
  • Hyperlipidemias / chemically induced
  • Hyperlipidemias / drug therapy
  • Hypolipidemic Agents* / administration & dosage
  • Hypolipidemic Agents* / pharmacokinetics
  • Interdisciplinary Communication*
  • Male

Substances

  • Androstadienes
  • Anti-Inflammatory Agents
  • Anti-Retroviral Agents
  • Hypolipidemic Agents
  • Fluticasone